Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracey A Cho

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
JAMA Neurology|June 23, 2020
Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy-Related InflammationRobert W Regenhardt, Jesse M Thon, Alvin S Das, et al.
Neurology|October 15, 2017
Infliximab for the treatment of CNS sarcoidosis: A multi-institutional seriesJeffrey M Gelfand, Michael J Bradshaw, Barney J Stern, et al.
Mbio|September 1, 2021
Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and EncephalitisAnne Piantadosi, Shibani S Mukerji, Simon Ye, et al.
Neurology. Clinical Practice|January 20, 2025
Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the United StatesGiovanna Sophia Manzano, James Eaton, Michael Levy, et al.
Journal for Immunotherapy of Cancer|October 15, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitorsLing Zhu, Yee-Ming M Cheung, Cherie Chiang, et al.
Annals of Clinical and Translational Neurology|September 18, 2025
A Multi-Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future DirectionsGiovanna S Manzano, Denis Balaban, Yihan Zhang, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitorsAmanda C Guidon, Leeann B Burton, Bart K Chwalisz, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
JAMA Neurology|June 23, 2020
Association Between Immunosuppressive Treatment and Outcomes of Cerebral Amyloid Angiopathy-Related InflammationRobert W Regenhardt, Jesse M Thon, Alvin S Das, et al.
Neurology|October 15, 2017
Infliximab for the treatment of CNS sarcoidosis: A multi-institutional seriesJeffrey M Gelfand, Michael J Bradshaw, Barney J Stern, et al.
Mbio|September 1, 2021
Enhanced Virus Detection and Metagenomic Sequencing in Patients with Meningitis and EncephalitisAnne Piantadosi, Shibani S Mukerji, Simon Ye, et al.
Neurology. Clinical Practice|January 20, 2025
Consensus Recommendations for the Management of Neurosarcoidosis: A Delphi Survey of Experts Across the United StatesGiovanna Sophia Manzano, James Eaton, Michael Levy, et al.
Journal for Immunotherapy of Cancer|October 15, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitorsLing Zhu, Yee-Ming M Cheung, Cherie Chiang, et al.
Annals of Clinical and Translational Neurology|September 18, 2025
A Multi-Center Retrospective Cohort Study of Neurosarcoidosis Myelitis: Current Observations and Future DirectionsGiovanna S Manzano, Denis Balaban, Yihan Zhang, et al.
Journal for Immunotherapy of Cancer|July 20, 2021
Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitorsAmanda C Guidon, Leeann B Burton, Bart K Chwalisz, et al.
Pageof 6